Improve the lives of more than 3 million people by 2030 through better prevention, cure and quality of life

Horizon Europe will incorporate, as a new element, research and innovation missions. One of the five missions is the Mission on Cancer. Each mission has a board of 15 experts, including a Chair, and is supported by a secretariat.

In June 2020 the interim report on the cancer mission was published. The report served as the basis for further discussion and engagement to ensure that the proposed mission is relevant and will make a real difference. At the European Research and Innovation Days in September 2020, the board of experts presented its recommendations to the Commission. Further to this, the Mission was launched in September 2021 with the publication of its implementation plan and factsheet

The Mission on Cancer aims to improve the lives of more than 3 million people through prevention and cure, as well as support individuals and their families affected by cancer to have longer and better lives by supporting the EU's Beating Cancer Plan. Several initiatives will be established as part of the Mission, including the creation of the EU Platform UNCAN.eu by 2023, to lead to more rapid breakthroughs in understanding cancer, and the European Cancer Patient Digital Centre also by 2023, to empower patients in their care. By 2025 a network of Comprehensive Cancer Infrastructures will be created, enhancing the quality of care and decreasing barriers to access of care. 

cancer mission

ERRIN input


In healthcare – including research, prevention, treatment, and monitoring – regional and local authorities are vital actors as they lead, promote, and financially support research and innovation agendas, while also acting as health and care providers. Regions can be key in developing effective cancer prevention strategies and optimising existing screening programmes as recommended in the mission outline. Through their ecosystem, regions are closely connected to both professionals and research centres and institutes specialised in cancer and of course, to citizens to engage them in accomplishing this mission.

In July 2020, the Health WG organised a webinar to discuss the development of the Mission on Cancer with one of the Mission Board members. Following this, in October 2020 ERRIN's Health WG developed and released a joint statement with EUREGHA calling for the regional dimension of the Mission to be clearly defined and included in its design and implementation. 

Next steps: In 2021, the Health WG continues to follow the Mission closely and is looking at the opportunities for regions presented in the implementation plan. 

Context


Cancer is one of Europe’s five major societal challenges and the projection is that, without strong action, the number of diagnosed cases will increase by a fourth by 2035. Every year, 2.7 million people in the EU-27 are diagnosed with cancer. Across Europe, the possibility of receiving a timely cancer diagnosis and of surviving the disease differs considerably because of inequalities in access to knowledge, prevention, diagnostics, treatments and care. With the number of cancer diagnoses and deaths expected to increase due to ageing populations, unhealthy lifestyles, unfavourable health determinants and environmental and working conditions, these trends are at risk of being exasperated by the COVID-19 pandemic. 

Cancer puts immense pressure on European health systems and so the Mission on Cancer aims to offer a distinct and comprehensive approach by bringing together research, innovation and policy development. 

Latest Updates

  • By Lucy Hammond

European Cancer Imaging Initiative launched

Earlier this week, the European Commission launched the European Cancer Imaging Initiative, part of Europe's Beating Cancer Plan. The initiative will support healthcare providers, research institutes and innovators in making the best use of innovative data-driven solutions for cancer treatment and care. The first version of the platform is expected to be released by the end of 2024, with the final release expected by the end of 2025

  • By Ewa Chomicz

Largest public consultation on Horizon programmes 2014-2027 now open

The Commission has launched the largest public consultation ever held on the past, present and future of the European Research & Innovation Framework Programmes 2014-2027. Stakeholders are invited to share their views on the performance of Horizon 2020 and Horizon Europe, as well as shaping the strategic orientations for the Horizon Europe Strategic Plan 2025-2027. The consultation will stay open for 12 weeks, closing in February 2023.

  • By Ewa Chomicz

New members of the EU Missions Boards announced

Yesterday the European Commission announced 75 new top experts who will advise on the five EU Missions through serving on their Boards. ERRIN is thrilled that Françoise Guaspare from Île-de-France Europe, one of the Transport Working Group leaders, will join the Mission Board of the Climate-Neutral and Smart Cities Mission.

  • By Ewa Chomicz

ERRIN autumn perspectives: R&I policy outlook

The first half of 2022 offered several key policy developments. To kick off the autumn, we propose a short outlook of what will keep ERRIN busy when it comes to the R&I policy perspective.

  • By Ewa Chomicz

ERRIN input to call for evidence for Horizon Europe interim evaluation

ERRIN has submitted its messages in response to the European Commission's call for evidence for the Horizon Europe programme interim evaluation.

  • By Hilary Webb

ERRIN messages on Horizon Europe Missions Work Programmes 2023-2024

In the context of the Horizon Europe Missions Work Programme 2023-2024 that is currently underway at the European Commission, ERRIN is pleased to share its messages on the Mission work programmes for 2023-2024 and the involvement of regional actors within the Missions.